Loading...
Strategies and Endpoints of Antifibrotic Drug Trials
There is an urgent need to develop antifibrotic therapies for chronic liver disease, and to clarify which endpoints in antifibrotic trials will be acceptable to regulatory agencies. AASLD sponsored an endpoints conference to help accelerate the efficient testing of antifibrotic agents and to develop...
Na minha lista:
| Udgivet i: | Hepatology |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515973/ https://ncbi.nlm.nih.gov/pubmed/25626988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27720 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|